X0306 4 2016-05-13 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001600522 Meng Chuncai 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 Gen. Counsel & VP Compliance Non-Qualified Stock Option (right to buy) 12.71 2016-05-13 4 A 0 21000.0 0.0 A 2026-05-13 Common Stock 21000 21000 D Restricted Stock Unit 2016-05-13 4 A 0 3000.0 0.0 A Common Stock 3000 6000 D Granted under the Issuer's 2015 Equity Incentive Plan. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Vesting for such RSUs will occur 25% on May 13, 2017, 25% on May 13, 2018, 25% on May 13, 2019, and 25% on May 13, 2020, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. By: /s/ Friedhelm Blobel, Attorney-in-Fact For: Chuncai Meng 2016-05-16